NBSGW mice crossed with HLA-A2/HHD mice have a c-kit mutation and human HLA class I heavy and light chains that limit the ability of mouse HSCs to compete with human HSCs and enable T cell selection against human antigens, enabling silicified cancer cells to activate human immune cells against cancer. Here, KIT is linked to cancer.